Brainchip (ASX:BRN): All systems go in 2024!

Interview with Archer Materials (ASX:AXE) CTO Simon Ruffell

Weebit Nano (ASX:WBT) is on track for more commercial deals in 2024

Actinogen Medical (ASX:ACW): Interview with CEO Dr Steve Gourlay

Chimeric Therapeutics (ASX:CHM): Good prospects for licensing deals

BrainChip (ASX:BRN): Post AGM interview with CEO Sean Hehir

Interview with Dr Paul Dalgleish, Managing Director of GreenHy2 (ASX: H2G).

WhiteHawk (ASX:WHK): Many opportunities in Cyber Security for the taking

Transition Resources (Pre IPO): Interview with MD David Wilson

Intelligent Monitoring Group (ASX:IMB): Interview with Executive Director Dennison Hambling

Future Battery Minerals (ASX:FBM) interview with CEO Nick Rathjen

Black Rock Mining (ASX:BKT): Its graphite project is in a great position

Oceana Lithium (ASX:OCN) interview with CEO Caue Araujo

Xamble (ASX:XGL) interview with Chairman Bangah and director Chmiel

Weebit Nano interview: We're shooting the breeze with WBT's CEO and Chair

Dimerix (ASX:DXB) shows encouraging Phase 3 interim results! Interview with CEO Dr. Nina Webster

Brainchip (ASX:BRN): All systems go in 2024!

4DS Memory (ASX:4DS): A non-volatile memory for the fast-growing Artificial Intelligence (AI) market

Archer Materials (ASX:AXE): Interview with CEO Mohammad Choucair about AXE's paradigm-shifting Tech

Dimerix (ASX:DXB) Phase 2 interim data reading should be out soon!

Weebit Nano (ASX:WBT) looks like it may be hitting some very big milestones in 2024!

Immuron (ASX:IMC): Clinical data imminent!

Dimerix' (ASX:DXB) interim analysis imminent. Interview with CEO Dr. Nina Webster.

ASX Uranium stocks are back, baby!! Investor Webinar 20 December 2023

Dissecting the Woodside Santos merger and opportunities on NASDAQ: Investor Webinar 13 December 2023